Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1987 Mar;146(3):322–327.

Acute Promyelocytic Leukemia

Edwin C Kingsley 1,2,3, Brian G M Durie 1,2,3, Harinder S Garewal 1,2,3
PMCID: PMC1307278  PMID: 3472414

Abstract

Acute promyelocytic leukemia (APL) is a subtype of acute myelogenous leukemia frequently associated with disseminated intravascular coagulation (DIC). Data on 11 patients with APL treated at our institution were analyzed and compared with those of 147 published cases. Most had a bleeding diathesis at presentation and evidence of DIC eventually developed in all. Seven patients (64%) showed the t(15;17)(q22;q21) karyotype or a similar translocation. Using a chemotherapy induction regimen containing an anthracycline, complete remission, requiring a total of 14 courses of treatment, was achieved in six patients (55%). The median duration of response and median survival for complete responders were 10 and 15 months, respectively. Three patients (27%) died of bleeding complications during induction therapy. The tritiated-thymidine labeling index of leukemia cells predicted which patients would achieve a complete remission. Review of six studies of 147 patients with APL from the past 12 years supports the use of a chemotherapy induction regimen containing anthracycline or amsacrine and heparin for the treatment of DIC.

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arlin Z., Kempin S., Mertelsmann R., Gee T., Higgins C., Jhanwar S., Chaganti R. S., Clarkson B. Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy. Blood. 1984 Jan;63(1):211–212. [PubMed] [Google Scholar]
  2. BAKER W. G., BANG N. U., NACHMAN R. L., RAAFAT F., HOROWITZ H. I. HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING. Ann Intern Med. 1964 Jul;61:116–123. doi: 10.7326/0003-4819-61-1-116. [DOI] [PubMed] [Google Scholar]
  3. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  4. Bernard J., Weil M., Boiron M., Jacquillat C., Flandrin G., Gemon M. F. Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood. 1973 Apr;41(4):489–496. [PubMed] [Google Scholar]
  5. Collins A. J., Bloomfield C. D., Peterson B. A., McKenna R. W., Edson J. R. Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction. Arch Intern Med. 1978 Nov;138(11):1677–1680. doi: 10.1001/archinte.138.11.1677. [DOI] [PubMed] [Google Scholar]
  6. Drapkin R. L., Gee T. S., Dowling M. D., Arlin Z., McKenzie S., Kempin S., Clarkson B. Prophylactic heparin therapy in acute promyelocytic leukemia. Cancer. 1978 Jun;41(6):2484–2490. doi: 10.1002/1097-0142(197806)41:6<2484::aid-cncr2820410659>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  7. Durie B. G., Salmon S. E. High speed scintillation autoradiography. Science. 1975 Dec 12;190(4219):1093–1095. doi: 10.1126/science.1188385. [DOI] [PubMed] [Google Scholar]
  8. Golomb H. M., Rowley J., Vardiman J., Baron J., Locker G., Krasnow S. Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Arch Intern Med. 1976 Jul;136(7):825–828. [PubMed] [Google Scholar]
  9. Golomb H. M., Vardiman J., Rowley J. D. Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul;48(1):9–21. [PubMed] [Google Scholar]
  10. Gralnick H. R., Bagley J., Abrell E. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. Am J Med. 1972 Feb;52(2):167–174. doi: 10.1016/0002-9343(72)90066-6. [DOI] [PubMed] [Google Scholar]
  11. Kantarjian H. M., Keating M. J., McCredie K. B., Beran M., Walters R., Dalton W. T., Jr, Hittleman W., Freireich E. J. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia. J Clin Oncol. 1985 Jun;3(6):793–798. doi: 10.1200/JCO.1985.3.6.793. [DOI] [PubMed] [Google Scholar]
  12. Keane T. J., Gorman A. M., O'Connell L. G., Fennelly J. J. epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia. Acta Haematol. 1976;56(4):202–204. doi: 10.1159/000207938. [DOI] [PubMed] [Google Scholar]
  13. Larson R. A., Kondo K., Vardiman J. W., Butler A. E., Golomb H. M., Rowley J. D. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May;76(5):827–841. doi: 10.1016/0002-9343(84)90994-x. [DOI] [PubMed] [Google Scholar]
  14. NILSSON I. M., SJOERDSMA A., WALDENSTROM J. Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man. Lancet. 1960 Jun 18;1(7138):1322–1326. doi: 10.1016/s0140-6736(60)92305-9. [DOI] [PubMed] [Google Scholar]
  15. Ruggero D., Baccarani M., Guarini A., Gugliotta L., Gobbi M., Ricci P., Zaccaria A., Lauria F., Tomasini I., Fiacchini M. Acute promyelocytic leukemia: results of therapy and analysis of 13 cases. Acta Haematol. 1977;58(2):108–119. doi: 10.1159/000207816. [DOI] [PubMed] [Google Scholar]
  16. Sauter C., Berchtold W., Fopp M., Gratwohl A., Imbach P., Maurice P., Tschopp L., von Fliedner V., Cavalli F. Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival. Lancet. 1984 Feb 18;1(8373):379–382. doi: 10.1016/s0140-6736(84)90424-0. [DOI] [PubMed] [Google Scholar]
  17. Van Den Berghe H., Louwagie A., Broeckaert-Van Orshoven A., David G., Verwilghen R., Michaux J. L., Sokal G. Chromosome abnormalities in acute promyelocytic leukemia (APL). Cancer. 1979 Feb;43(2):558–562. doi: 10.1002/1097-0142(197902)43:2<558::aid-cncr2820430223>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES